TCBWMS
APTO

Texas Capital Bank Wealth Management Services’s Aptose Biosciences, Inc. APTO Stock Holding History

Texas Capital Bank Wealth Management Services’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-415
Closed -$5.12K – 213
2024
Q3 		$5.12K Hold
415
– – ﹤0.01% 204
2024
Q2 		$9.45K Hold
415
– – ﹤0.01% 199
2024
Q1 		$20.7K Hold
415
– – ﹤0.01% 198
2023
Q4 		$31.6K Buy
+415
New +$32.2K ﹤0.01% 201
2022
Q1 		– Sell
-56
Closed -$34K – 185
2021
Q4 		$34K Buy
+56
New +$52.6K ﹤0.01% 157

Other funds holding APTO

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $2.09B AUM 34.27% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Texas Capital Bank Wealth Management Services's APTO Position: Q4 2024 in Review

Texas Capital Bank Wealth Management Services sold out of Aptose Biosciences, Inc. (APTO) in Q4 2024, closing a stake of 415 shares — an estimated $5.12K sold.

Texas Capital Bank Wealth Management Services first reported a position in APTO in Q4 2021 and held it in 5 quarters. The position peaked at $34K in Q4 2021. 22 funds tracked by Wall St. Rank hold APTO as of Q4 2024.

  • Texas Capital Bank Wealth Management Services reported no remaining Aptose Biosciences, Inc. position as of Q4 2024 after selling out during the quarter.
  • Texas Capital Bank Wealth Management Services sold 415 Aptose Biosciences, Inc. shares in Q4 2024, an estimated $5.12K.
  • Texas Capital Bank Wealth Management Services first reported a position in Aptose Biosciences, Inc. in Q4 2021 and held it in 5 quarters.
  • Texas Capital Bank Wealth Management Services's Aptose Biosciences, Inc. position peaked at $34K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2024.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q4 2024, filed 13 Feb 2025.